Ambulatory Venous Hypertension Components Obstruction Valve incompetence Obstruction Valve incompetence Obstruction and valve incompetence …Highest venous.

Slides:



Advertisements
Similar presentations
Giancarlo Agnelli Università di Perugia Anticoagulant treatment for PE: optimal duration.
Advertisements

Frank R. Arko, MD Associate Professor of Surgery
Rocky Mountain ACP Internal Medicine Conference November 22, 2012 Brian Wirzba, MD, FRCPC, FACP.
The Perplexing Perforator: SEPS, PAPS, nothing
Suresh Vedantham, M.D. Interventional Radiologist Associate Professor of Radiology & Surgery Washington University School of Medicine Vice-Chair, Venous.
Aggressive Management of Chronic Deep Venous Thrombosis: Technical and Clinical Outcomes Mark J. Garcia M.D. FSIR C Grilli, M McGarry, M Ali, D Agriantonus,
Chapter Six Venous Disease Coalition Acute Management of VTE VTE Toolkit.
Results: 1.Progression of thrombus length and volume (40% vs. 28%; P
Long-Term Outcome After Additional Catheter-Directed Thrombolysis versus Standard Treatment for Acute Iliofemoral Deep Vein Thrombosis (The CaVenT Study):
Antithrombotic Therapy for Venous Thromboembolic Diseases
Chapter Eleven Venous Disease Coalition Chronic Venous Insufficiency VTE Toolkit.
Joint Hospital Surgical Grand Round
Prophylaxis of Venous Thromboembolism
Submassive Pulmonary Emboli: New Therapeutic Strategies
Below the Knee DVT and Pregnancy Related Thrombosis Robert Lampman, MD Morning Report July 2009.
EKG at presentation. EKG next day Initial EKG F/u EKG.
Anticoagulation in Acute Ischemic Stroke. TPA: Tissue Plasminogen Activator 1995: NINDS study of TPA administration Design: randomized, double blind placebo-controlled.
TOTAL Stroke in the TOTAL trial: Randomized trial of manual aspiration Thrombectomy in STEMI TOTAL Trial Investigators.
DPT 732 SPRING 2009 S. SCHERER Deep Vein Thrombosis.
Venous thromboembolism: how long to treat?
Deep vein thrombosis. Color duplex scan of DVT Venogram shows DVT.
LIFEBLOOD THE Thrombosis CHARITY Venous thromboembolism – Treatment and secondary prevention Ulcus cruris Chronic PE PE DVT Post-thrombotic syndrome Death.
Deep Vein Thrombosis Deep Vein Thrombosis DVT facts, statistics, and therapeutic options MICHAEL A ARATA MD INTERVENTIONAL RADIOLOGY INTERVENTIONAL RADIOLOGY.
Chapter Nine Venous Disease Coalition New Therapies for VTE VTE Toolkit.
Isolated Thrombolysis for DVT DVT Treatment with the Trellis ® Peripheral Infusion System Manufacturer’s Registry Report Gerard J. O’Sullivan MD Mahmood.
Medical Patients – VTE Prevention Dale W. Bratzler, DO, MPH Professor and Associate Dean, College of Public Health Professor of Medicine, College of Medicine.
Prevention Of Venous Thromboembolism In The Cancer Surgical Patient A K Kakkar Barts and the London School of Medicine and Thrombosis Research Institute,
Renal vein thrombosis Nephrology discussion Dr. Coetser Prof. Van Rensburg and dr. Rossouw.
7th ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines.
ANTICOAGULATION THERAPY OR CATHETER DIRECTED THROMBOLYSIS Alice Marinho, Carlos Veterano, Maricruz Nunes, Patrícia Baptista, Pedro Aguiar, Pedro Campelo,
CARDIOVASCULAR MODULE: DEEP VENOUS THROMBOSIS THROMBOPHLEBITIS Adult Medical-Surgical Nursing.
Pulmonary Embolism Treatment in Cancer - Is It Different 34th Brazilian Thoracic Conference 6th ALAT Congress 5th Brazil-Portugal Congress Brazilia/DF.
MANAGEMENT OF POST-ENDOVENOUS ABLATION VENOUS THROMBOSIS Stephen F. Daugherty, MD, FACS Clarksville, Tennessee, USA.
Acute venous or arterial thrombosis Acute venous or arterial thrombosis Is there clinical concern for an anatomic compressive syndrome or occlusive iliofemoral.
Interesting Case Presentation March 1, 2012 Franklin C. Margaron, MD.
Presented by: Passant Mounir Nagy Under the supervision of: Prof. Dr/ Seham Hafez.
Deep vein thrombosis Pulmonary embolism Deep vein thrombosis Pulmonary embolism Venous Thromboembolism TreatmentTreatment …All the same?
CHRONIC ILIOFEMORAL DVT NEVER TOO LATE Stephen F. Daugherty, MD, FACS, RVT, RPhS Clarksville, Tennessee ACP NOVEMBER, 2012.
Cost-Consciousness Assignment Ollie Ross DSR 2. Adherence to ACP DVT prophylaxis guidelines Objective: Evaluate adherence to ACP DVT prophylaxis guidelines.
Acute Venous Pulmonary Embolism Restore cardiopulmonary hemodynamics Avoid recurrence Avoid chronic thromboembolic pulmonary hypertension Restore cardiopulmonary.
Risk Assessment for VTE. Which of the following best describes you?
Duration of Anticoagulation 5 Patients Categories 3. First Episode: 4. First Episode: 5.Recurrent DVT 2. First Episode: 1. First Episode: Transient risk.
Suresh Vedantham, M.D. Professor of Radiology & Surgery Mallinckrodt Institute of Radiology Washington University in St. Louis Interventional Management.
Faisal Alam Consultant Vascular & General Surgeon Royal Hospital.
Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing June 2012 NICE clinical guideline.
Preoperative Angiographic Diagnosis of Insufficient Venous Valve : A Case Report Ya Ju, Chang Department of Radiology, Ditmanson Medical Foundation Chia-Yi.
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Antithrombotic Therapy and Prevention of Thrombosis: ACCP Evidence-Based Clinical Practice.
Conclusions Results Methods Background Venous thrombo-embolism in patients undergoing neo- adjuvant chemotherapy and surgery for oesophago-gastric cancer.
Treatment of deep venous thrombosis and pulmonary embolism Anders Waage.
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Antithrombotic Therapy and Prevention of Thrombosis: ACCP Evidence-Based Clinical Practice.
The GREAT Trial. The Grampian Region Early Anistreplase Trial Reference Zahringer M, Sapoval M, Pattynama PM, et al. Sirolimus-eluting versus bare-metal.
Catheter-Based Treatment of DVT: Who & When?
Clinical case Case Presentation: IVC Retrievable and Permanent Filters
Epidemiology and Natural history of Venous Obstruction/Compression
Current Standards for Treatment of DVT
Intervention for Chronic Lower Extremity Venous Obstruction
Treatment of VTE Guidelines
Deep Vein Thrombosis & Pulmonary Embolism
Deep Venous Thrombosis Anthony J. Comerota, MD, FACS, FACC
Treatment of iliac vein obstruction
Treatment of iliac vein obstruction
Aspiration with Thrombolysis for Massive Pulmonary Embolism
A.Postadzhiyan, MD, PhD St Anna University Hospital, Sofia, Bulgaria
Clinical Presentations of VTEa,b NOACs VTE Acute Treatment Trials.
A strategy of aggressive regional therapy for acute iliofemoral venous thrombosis with contemporary venous thrombectomy or catheter-directed thrombolysis 
Modified Rankin score 0-2
Post-thrombotic Syndrome.
Quantity of clot lysed after catheter-directed thrombolysis for iliofemoral deep venous thrombosis correlates with postthrombotic morbidity  Nina K. Grewal,
CHAMPION Trial design: Patients with recent hospitalization for heart failure were implanted with a pulmonary artery pressure monitor and randomized so.
DENERHTN Trial design: Patients with resistant hypertension were randomized to renal denervation plus standardized stepped-care antihypertensive treatment.
Presentation transcript:

Ambulatory Venous Hypertension Components Obstruction Valve incompetence Obstruction Valve incompetence Obstruction and valve incompetence …Highest venous pressure …Most severe morbidity …Highest venous pressure …Most severe morbidity

Iliofemoral DVT Contraindication to Lysis Yes No Surgical Thrombectomy + AVF Surgical Thrombectomy + AVF Anticoagulation Catheter-directed Thrombolysis Catheter-directed Thrombolysis Success Yes No

63 patients: iliofemoral DVT Thrombectomy + AVF vs. Anticoagulation Follow-up: 6 mos, 5 yrs, 10 yrs Patency –Valve function –Venous hemodynamics –Clinical evaluation 63 patients: iliofemoral DVT Thrombectomy + AVF vs. Anticoagulation Follow-up: 6 mos, 5 yrs, 10 yrs Patency –Valve function –Venous hemodynamics –Clinical evaluation Plate G et al, J Vasc Surg 1984 Venous Thrombectomy vs. Anticoagulation Randomized Trial

Anticoag. Thrombectomy 60 mmHg 43 mmHg AVP 27% 11% Severe CVI 18% 37% Asymptomatic 37% 7% Reflux + obstruction 6% 40% N Valve fct. (fempop) 50% 78% Patent iliac* Plate G et al, Eur J Vasc Endovasc Surg 1990 Plate G et al, Eur J Vasc Endovasc Surg 1990 Venous Thrombectomy vs. Anticoagulation Results: 5 years (n=41) *radionuclide phlebography

Acute DVT “…There is no evidence that supports the use of thrombolytic agents for the initial treatment of DVT….” Thrombolytic Therapy: ACCP 2004 Buller H, et al Chest 2004;126:401S Buller H, et al Chest 2004;126:401S Recommend against the routine use of catheter- directed thrombolysis (Grade 1C) …Treatment..[with lytic Rx].. Be confined to patients requiring limb salvage. (Grade 2C)

Catheter-Directed Lysis Iliofemoral DVT Significantly better QOL with lysis Physical functionStigma Health distressPost thromb Sx Successful lysis correlated w/QOL Lytic failures and heparin Rx similar Significantly better QOL with lysis Physical functionStigma Health distressPost thromb Sx Successful lysis correlated w/QOL Lytic failures and heparin Rx similar Improvement in Quality of Life Comerota AJ et al J Vasc Surg 2000 Comerota AJ et al J Vasc Surg 2000

35 consecutive patients Iliofemoral DVT Randomized Follow-up 1week/6mos –Clot lysis –Venous reflux 35 consecutive patients Iliofemoral DVT Randomized Follow-up 1week/6mos –Clot lysis –Venous reflux Cath-dir SK (pulse spray) vs. Anticoagulation alone Cath-dir SK (pulse spray) vs. Anticoagulation alone Elsharawy M, et al Eur J Vas Surg. 2002; 24:209 Elsharawy M, et al Eur J Vas Surg. 2002; 24:209 Catheter-Directed Lysis Iliofemoral DVT Improvement in Quality of Life

Elsharawy M, et al Eur J Vas Surg. 2002; 24:209 Elsharawy M, et al Eur J Vas Surg. 2002; 24: d 6d LOS % 41%* Reflux < % 12% Patency P-valve Lysis (n=18) Lysis (n=18) Anticoag (n=17) Anticoag (n=17) *Underestimate 2 0 occlusion Catheter-Directed Lysis Iliofemoral DVT Randomized Trial: Outcome at 6 months

Postthrombotic Syndrome Elastic Stockings (30-40 mmHg) Lancet 1997;349:759 <.01 51% 24% 49% <.01 55% 21% 47% P-value RRR Stocking Control Postthrombotic Syndrome Brandjes DP Prandoni P (n=194) (n=170) Patho Hemst Thromb 2002;32(suppl 2):72

A Strategy of Thrombus Removal for Venous Thromboembolism: We Owe it to Our Patients